Patient Feedback Spurs Expansion of ADDRESS-LC Trial: More Test Sites, Broader Enrollment
In July, Solve hosted a webinar featuring representatives of the ADDRESS-LC Trial, which was designed
September 23, 2025
In July, Solve hosted a webinar featuring representatives of the ADDRESS-LC Trial, which was designed
Solve Board Member Cynthia Adinig has been selected as a member of the Health and
The PolyBio Research Foundation recently hosted its fall research symposium featuring project updates from some
At Solve M.E., our mission is to drive research and advocacy efforts for Myalgic Encephalomyelitis/Chronic
The National Academies of Sciences, Engineering, and Medicine (NASEM), a nongovernmental institution that advises federal
In an effort to move the ME/CFS field toward translational studies and clinical trials, the
Solve community member Rebecca Groble Hull successfully advocated for Evanston, Illinois Mayor Daniel Bliss to
On March 15, Long Covid Awareness Day, Solve’s VP of Advocacy and Engagement Emily Taylor
Dear Friends, I am deeply saddened to learn of the passing of #MEAction co-founder and
In 2012, the Centers for Disease Control and Prevention (CDC) initiated its multi-site clinical assessment
Recently released papers with findings from two National Institutes of Health-funded studies by the Center
On May 12th each year, we focus a day on learning about, raising awareness of,
Move science forward with a gift to Solve today.